255 related articles for article (PubMed ID: 35582577)
1. Cancer drug resistance: rationale for drug delivery systems and targeted inhibition of HSP90 family proteins.
Mathieu C; Messaoudi S; Fattal E; Vergnaud-Gauduchon J
Cancer Drug Resist; 2019; 2(3):381-398. PubMed ID: 35582577
[TBL] [Abstract][Full Text] [Related]
2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
3. TRAP1: a viable therapeutic target for future cancer treatments?
Lettini G; Maddalena F; Sisinni L; Condelli V; Matassa DS; Costi MP; Simoni D; Esposito F; Landriscina M
Expert Opin Ther Targets; 2017 Aug; 21(8):805-815. PubMed ID: 28664757
[TBL] [Abstract][Full Text] [Related]
4. Paralog Specificity Determines Subcellular Distribution, Action Mechanism, and Anticancer Activity of TRAP1 Inhibitors.
Park HK; Jeong H; Ko E; Lee G; Lee JE; Lee SK; Lee AJ; Im JY; Hu S; Kim SH; Lee JH; Lee C; Kang S; Kang BH
J Med Chem; 2017 Sep; 60(17):7569-7578. PubMed ID: 28816449
[TBL] [Abstract][Full Text] [Related]
5. TRAP1 regulation of mitochondrial life or death decision in cancer cells and mitochondria-targeted TRAP1 inhibitors.
Kang BH
BMB Rep; 2012 Jan; 45(1):1-6. PubMed ID: 22281005
[TBL] [Abstract][Full Text] [Related]
6. Development of a mitochondria-targeted Hsp90 inhibitor based on the crystal structures of human TRAP1.
Lee C; Park HK; Jeong H; Lim J; Lee AJ; Cheon KY; Kim CS; Thomas AP; Bae B; Kim ND; Kim SH; Suh PG; Ryu JH; Kang BH
J Am Chem Soc; 2015 Apr; 137(13):4358-67. PubMed ID: 25785725
[TBL] [Abstract][Full Text] [Related]
7. New insights into molecular chaperone TRAP1 as a feasible target for future cancer treatments.
Li XT; Li YS; Shi ZY; Guo XL
Life Sci; 2020 Aug; 254():117737. PubMed ID: 32376268
[TBL] [Abstract][Full Text] [Related]
8. New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.
Rondanin R; Lettini G; Oliva P; Baruchello R; Costantini C; Trapella C; Simoni D; Bernardi T; Sisinni L; Pietrafesa M; Ponterini G; Costi MP; Vignudelli T; Luciani R; Matassa DS; Esposito F; Landriscina M
Bioorg Med Chem Lett; 2018 Jul; 28(13):2289-2293. PubMed ID: 29807796
[TBL] [Abstract][Full Text] [Related]
9. Development of pyrazolo[3,4-d]pyrimidine-6-amine-based TRAP1 inhibitors that demonstrate in vivo anticancer activity in mouse xenograft models.
Kim D; Kim SY; Kim D; Yoon NG; Yun J; Hong KB; Lee C; Lee JH; Kang BH; Kang S
Bioorg Chem; 2020 Aug; 101():103901. PubMed ID: 32590225
[TBL] [Abstract][Full Text] [Related]
10. Insights from yeast into whether the inhibition of heat shock transcription factor (Hsf1) by rapamycin can prevent the Hsf1 activation that results from treatment with an Hsp90 inhibitor.
Millson SH; Piper PW
Oncotarget; 2014 Jul; 5(13):5054-64. PubMed ID: 24970820
[TBL] [Abstract][Full Text] [Related]
11. Mechanisms of Resistance to Hsp90 Inhibitor Drugs: A Complex Mosaic Emerges.
Piper PW; Millson SH
Pharmaceuticals (Basel); 2011 Oct; 4(11):1400-1422. PubMed ID: 27721330
[TBL] [Abstract][Full Text] [Related]
12. Targeting mitochondrial biogenesis to overcome drug resistance to MAPK inhibitors.
Zhang G; Frederick DT; Wu L; Wei Z; Krepler C; Srinivasan S; Chae YC; Xu X; Choi H; Dimwamwa E; Ope O; Shannan B; Basu D; Zhang D; Guha M; Xiao M; Randell S; Sproesser K; Xu W; Liu J; Karakousis GC; Schuchter LM; Gangadhar TC; Amaravadi RK; Gu M; Xu C; Ghosh A; Xu W; Tian T; Zhang J; Zha S; Liu Q; Brafford P; Weeraratna A; Davies MA; Wargo JA; Avadhani NG; Lu Y; Mills GB; Altieri DC; Flaherty KT; Herlyn M
J Clin Invest; 2016 May; 126(5):1834-56. PubMed ID: 27043285
[TBL] [Abstract][Full Text] [Related]
13. Rational Design of Allosteric and Selective Inhibitors of the Molecular Chaperone TRAP1.
Sanchez-Martin C; Moroni E; Ferraro M; Laquatra C; Cannino G; Masgras I; Negro A; Quadrelli P; Rasola A; Colombo G
Cell Rep; 2020 Apr; 31(3):107531. PubMed ID: 32320652
[TBL] [Abstract][Full Text] [Related]
14. Discovery of 2-((4-resorcinolyl)-5-aryl-1,2,3-triazol-1-yl)acetates as potent Hsp90 inhibitors with selectivity over TRAP1.
Jung S; Yoon NG; Yang S; Kim D; Lee WS; Hong KB; Lee C; Kang BH; Lee JH; Kang S
Bioorg Med Chem Lett; 2020 Jan; 30(2):126809. PubMed ID: 31839539
[TBL] [Abstract][Full Text] [Related]
15. Resistance to paclitxel in breast carcinoma cells requires a quality control of mitochondrial antiapoptotic proteins by TRAP1.
Maddalena F; Sisinni L; Lettini G; Condelli V; Matassa DS; Piscazzi A; Amoroso MR; La Torre G; Esposito F; Landriscina M
Mol Oncol; 2013 Oct; 7(5):895-906. PubMed ID: 23735188
[TBL] [Abstract][Full Text] [Related]
16. Heat shock proteins, cell survival and drug resistance: the mitochondrial chaperone TRAP1, a potential novel target for ovarian cancer therapy.
Landriscina M; Amoroso MR; Piscazzi A; Esposito F
Gynecol Oncol; 2010 May; 117(2):177-82. PubMed ID: 19942270
[TBL] [Abstract][Full Text] [Related]
17. Overcoming acquired resistance to HSP90 inhibition by targeting JAK-STAT signalling in triple-negative breast cancer.
Mumin NH; Drobnitzky N; Patel A; Lourenco LM; Cahill FF; Jiang Y; Kong A; Ryan AJ
BMC Cancer; 2019 Jan; 19(1):102. PubMed ID: 30678647
[TBL] [Abstract][Full Text] [Related]
18. Targeting heat shock response to sensitize cancer cells to proteasome and Hsp90 inhibitors.
Zaarur N; Gabai VL; Porco JA; Calderwood S; Sherman MY
Cancer Res; 2006 Feb; 66(3):1783-91. PubMed ID: 16452239
[TBL] [Abstract][Full Text] [Related]
19. Suppression of heat shock protein 27 using OGX-427 induces endoplasmic reticulum stress and potentiates heat shock protein 90 inhibitors to delay castrate-resistant prostate cancer.
Lamoureux F; Thomas C; Yin MJ; Fazli L; Zoubeidi A; Gleave ME
Eur Urol; 2014 Jul; 66(1):145-55. PubMed ID: 24411988
[TBL] [Abstract][Full Text] [Related]
20. Hsp90 inhibitors and the reduction of anti-cancer drug resistance by non-genetic and genetic mechanisms.
Lu X; Wang L; Ruden DM
Pharmaceuticals (Basel); 2012 Aug; 5(9):890-8. PubMed ID: 24280696
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
